CC
CLVS

CQS Cayman’s Clovis Oncology, Inc. CLVS Stock Holding History

CQS Cayman’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-105,000
Closed -$5.88M – 245
2014
Q4 		$5.88M Sell
105,000
-20,000
-16% -$1.05M 0.39% 66
2014
Q3 		$5.67M Buy
+125,000
New +$5.22M 0.34% 75

Other funds holding CLVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

CQS Cayman's CLVS Position: Q1 2015 in Review

CQS Cayman sold out of Clovis Oncology, Inc. (CLVS) in Q1 2015, closing a stake of 105,000 shares — an estimated $5.88M sold.

CQS Cayman first reported a position in CLVS in Q3 2014 and held it in 2 quarters. The position peaked at $5.88M in Q4 2014. 152 funds tracked by Wall St. Rank hold CLVS as of Q1 2015.

  • CQS Cayman reported no remaining Clovis Oncology, Inc. position as of Q1 2015 after selling out during the quarter.
  • CQS Cayman sold 105,000 Clovis Oncology, Inc. shares in Q1 2015, an estimated $5.88M.
  • CQS Cayman first reported a position in Clovis Oncology, Inc. in Q3 2014 and held it in 2 quarters.
  • CQS Cayman's Clovis Oncology, Inc. position peaked at $5.88M in Q4 2014.
  • 152 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2015.

Based on CQS Cayman's 13F filing for Q1 2015, filed 13 May 2015.